+3 more

Solve them accordingly

Reading File

analyse_media

I have all the questions from the images. Let me now provide comprehensive answers for all 6 stations.

STATION 2 (10 Marks) - TOTAL PROTEINS

Case: 55-year-old male, exertional fatigue, Hb 10.6 g/dL, occult lytic skull lesions, prominent M-band on serum protein electrophoresis.

Q1. Probable Diagnosis (1M)

Multiple Myeloma (Plasma Cell Myeloma)

Classic triad: lytic bone lesions + anaemia + M-band (monoclonal protein) on electrophoresis.

Q2. Principle of Estimation & Reference Ranges for Total Protein and Albumin (3M)

Total Protein - Biuret Method: In an alkaline solution, proteins containing two or more peptide bonds react with copper sulfate (CuSO₄) to form a violet-coloured chelate complex. The absorbance is measured at 540 nm. Intensity of colour is proportional to the protein concentration (Beer-Lambert Law).

Serum Albumin - Bromocresol Green (BCG) Method: Albumin binds selectively to the dye Bromocresol Green at pH 4.2 (acetate buffer) to form a green-coloured complex. Absorbance is read at 628 nm. Colour intensity is directly proportional to albumin concentration.

Biological Reference Ranges:

Parameter	Reference Range
Serum Total Protein	6.0 - 8.0 g/dL
Serum Albumin	3.5 - 5.0 g/dL
Serum Globulin	2.0 - 3.5 g/dL
A:G Ratio	1.2 : 1 to 2 : 1

Q3. Calculate Concentration of Total Protein and Albumin (2M)

Formula (Beer-Lambert Law):

Concentration of Patient = (OD of Test / OD of Standard) × Concentration of Standard

(Note: Specific absorbance/OD values would be provided at the practical bench. Using typical OSPE calculation format:)

If OD_test(Total Protein) = 0.30, OD_std = 0.25, Std conc = 8 g/dL:

Total Protein = (0.30/0.25) × 8 = 9.6 g/dL

If OD_test(Albumin) = 0.22, OD_std = 0.20, Std conc = 4 g/dL:

Albumin = (0.22/0.20) × 4 = 4.4 g/dL
Globulin = Total Protein - Albumin = 9.6 - 4.4 = 5.2 g/dL
A:G Ratio = 4.4 / 5.2 = 0.85 (reversed/low)

Q4. Causes of Increased and Decreased Serum Total Protein (2M)

Increased (Hyperproteinaemia):

Dehydration / haemoconcentration (relative increase)
Multiple myeloma (excess immunoglobulins - M-protein)
Chronic infections (e.g., TB, kala-azar)
Chronic liver disease (early)
Sarcoidosis

Decreased (Hypoproteinaemia):

Malnutrition / malabsorption (kwashiorkor)
Nephrotic syndrome (protein loss in urine)
Chronic liver disease (cirrhosis - decreased synthesis)
Burns (protein loss)
Protein-losing enteropathy
Dilutional (IV fluid overload)

Q5. Significance of A:G Ratio (2M)

Normal A:G ratio = 1.2:1 to 2:1 (albumin > globulin)
A:G ratio is reversed (< 1) when albumin decreases or globulin increases
Diagnostic significance:
- Reversed ratio seen in: multiple myeloma, chronic liver disease (cirrhosis), chronic infections, nephrotic syndrome (albumin lost preferentially)
- In this patient: multiple myeloma causes excess globulin (M-protein) → globulin > albumin → reversed A:G ratio
- Helps distinguish liver disease (low albumin) from myeloma (high globulin)
- A:G ratio < 1 in this case strongly supports the diagnosis of multiple myeloma

STATION B-2 - URIC ACID (Gout Case)

Case: 58-year-old retired major general, severe pain in 1st metatarsophalangeal (MTP) joint, non-vegetarian, chronic alcoholic, mild fever, swollen/warm/red big toe, urinary pH 4.5.

Q1. Probable Diagnosis (1M)

Gout (Acute gouty arthritis)

Classic podagra (1st MTP joint), hyperuricaemia, acidic urine, risk factors (non-vegetarian diet high in purines, alcohol, male sex).

Q2. Principle of Uric Acid Estimation (1M)

Uricase-Peroxidase (Enzymatic) Method: Uric acid is oxidized by the enzyme uricase to allantoin + H₂O₂. The H₂O₂ produced reacts with a chromogen (4-aminoantipyrine + 3,5-dichloro-2-hydroxybenzene sulphonate) in the presence of peroxidase to form a red-coloured quinoneimine complex. Absorbance is read at 505 nm. Intensity is proportional to uric acid concentration.

Alternatively, the older Phosphotungstic acid method: Uric acid reduces phosphotungstic acid to form a blue colour (tungsten blue), measured at 660 nm.

Q3. Calculate Concentration of Uric Acid (3M)

Formula:

Uric acid (mg/dL) = (OD_test / OD_standard) × Concentration of standard

(Using typical practical values - exact OD values provided at bench):

If OD_test = 0.250, OD_std = 0.180, Std = 10 mg/dL:

Uric acid = (0.250/0.180) × 10 = 13.9 mg/dL

Q4. Biological Reference Range (1M)

Group	Reference Range
Adult Males	3.5 - 7.2 mg/dL (208 - 428 µmol/L)
Adult Females	2.6 - 6.0 mg/dL (155 - 357 µmol/L)
Hyperuricaemia defined as	> 7.0 mg/dL (males), > 6.0 mg/dL (females)

Q5. Interpretation (2M)

The patient's serum uric acid is elevated (> 7.0 mg/dL) = hyperuricaemia
Clinical features (podagra, fever, warmth, redness) + hyperuricaemia + acidic urine (pH 4.5, which promotes uric acid crystal deposition) are consistent with acute gout
Acidic urine facilitates uric acid stone formation (uric acid is less soluble in acid urine)

Q6. Other Conditions with Raised Serum Uric Acid (2M)

Overproduction of uric acid:

Lesch-Nyhan syndrome (HGPRT deficiency)
Myeloproliferative disorders (leukaemia, lymphoma)
Polycythaemia vera
Haemolytic anaemia
Psoriasis
Chemotherapy/radiotherapy (tumour lysis syndrome)

Decreased renal excretion:

Chronic kidney disease (CKD)
Hypertension
Hypothyroidism
Drugs: diuretics (thiazides, furosemide), low-dose aspirin, ciclosporin

STATION B-2 - SERUM CREATININE

Case: 41-year-old male, longstanding hypertension, lethargy, lower extremity oedema, nausea, diagnosed with acute renal failure.

Q1. Principle of Serum Creatinine Estimation (1M)

Jaffe's Method (Alkaline Picrate Method): Creatinine reacts with picric acid in alkaline medium (sodium hydroxide) to form a red-orange coloured Janovsky complex (creatinine-picrate complex). The absorbance is measured at 520 nm. Colour intensity is directly proportional to creatinine concentration (Beer-Lambert Law).

Q2. Calculate Serum Creatinine (3M)

Formula:

Creatinine (mg/dL) = (OD_test / OD_standard) × Concentration of standard

(Using typical values provided at bench):

If OD_test = 0.30, OD_std = 0.20, Std concentration = 2 mg/dL:

Creatinine = (0.30/0.20) × 2 = 3.0 mg/dL

Q3. Biological Reference Range of Serum Creatinine (1M)

Group	Reference Range
Adult Males	0.7 - 1.3 mg/dL
Adult Females	0.6 - 1.1 mg/dL
Children	0.3 - 0.7 mg/dL

Q4. Interpretation (2M)

Serum creatinine is markedly elevated (e.g., 3.0 mg/dL) - well above normal
This confirms impaired renal function / acute kidney injury (AKI)
In the context of longstanding hypertension leading to hypertensive nephropathy, progressive glomerular damage reduces GFR, causing creatinine accumulation
Oedema results from fluid retention due to decreased GFR; nausea is from uraemia

Q5. Causes of Increased Serum Creatinine (2M)

Pre-renal: Decreased renal perfusion - dehydration, heart failure, shock, renal artery stenosis

Renal (Intrinsic):

Acute tubular necrosis (ATN)
Glomerulonephritis
Diabetic nephropathy
Hypertensive nephrosclerosis
Polycystic kidney disease
Drug-induced nephrotoxicity (NSAIDs, aminoglycosides, contrast agents)

Post-renal: Urinary obstruction - BPH, renal calculi, ureteric obstruction

Non-renal: Large muscle mass, rhabdomyolysis, high meat diet (dietary creatine)

Q6. Define Creatinine Clearance (1M)

Creatinine clearance is the volume of plasma cleared of creatinine by the kidneys per unit time (mL/min). It is used as an estimate of the glomerular filtration rate (GFR).

Formula:

Ccr (mL/min) = (Urine creatinine × Urine volume in mL/min) / Plasma creatinine

Normal: 85 - 125 mL/min (males); 75 - 115 mL/min (females). It decreases proportionally with declining renal function.

STATION B-2 - SERUM BILIRUBIN

Case: 45-year-old male, jaundice (yellowish sclera + skin) for 4 days, dark urine, fatigue, mild right upper quadrant discomfort. No alcohol, no medications, no prior liver disease. No hepatosplenomegaly. ALT: 100 U/L, AST: 98 U/L, ALP: 480 U/L, GGT: 250 U/L.

Q1. Principle of Serum Bilirubin Estimation (2M)

Jendrassik and Grof Method (Diazo method):

Total bilirubin: Bilirubin reacts with diazotised sulphanilic acid (diazo reagent) in the presence of an accelerator (caffeine-benzoate-acetate reagent) to form a blue-green coloured azo dye (azobilirubin). Absorbance is measured at 600 nm.
Conjugated (Direct) bilirubin: Conjugated bilirubin is water-soluble and reacts directly (without accelerator) with the diazo reagent. Measured at 600 nm.
Unconjugated (Indirect) bilirubin: Calculated as = Total Bilirubin - Conjugated Bilirubin.

Q2. Calculate Total, Conjugated, and Unconjugated Bilirubin (3M)

Formula:

Bilirubin (mg/dL) = (OD_test / OD_standard) × Concentration of standard

(Using typical practical values):

If OD_Total = 0.40, OD_std = 0.25, Std = 2 mg/dL:
- Total Bilirubin = (0.40/0.25) × 2 = 3.2 mg/dL
If OD_Direct = 0.32, OD_std = 0.25, Std = 2 mg/dL:
- Conjugated (Direct) Bilirubin = (0.32/0.25) × 2 = 2.56 mg/dL
Unconjugated (Indirect) Bilirubin = 3.2 - 2.56 = 0.64 mg/dL

Q3. Biological Reference Ranges (1M)

Parameter	Reference Range
Total Bilirubin	0.2 - 1.0 mg/dL
Conjugated (Direct) Bilirubin	0.0 - 0.3 mg/dL
Unconjugated (Indirect) Bilirubin	0.1 - 0.8 mg/dL

Q4. Interpretation (2M)

Total bilirubin is elevated (3.2 mg/dL) with a predominantly conjugated (direct) fraction - indicates obstructive/cholestatic jaundice
Markedly elevated ALP (480 U/L) and GGT (250 U/L) point to biliary obstruction (not hepatocellular damage)
Mildly elevated ALT/AST (100/98 U/L) suggest secondary hepatocyte involvement
No alcohol, no drugs, no prior liver disease → most likely obstructive jaundice due to choledocholithiasis (common bile duct stone) or extrahepatic biliary obstruction
Dark urine = conjugated bilirubin excreted in urine (water-soluble)

Q5. Pre-hepatic and Hepatic Causes of Raised Serum Bilirubin (2M)

Pre-hepatic (Unconjugated hyperbilirubinaemia):

Haemolytic anaemia (hereditary spherocytosis, sickle cell, G6PD deficiency)
Incompatible blood transfusion
Physiological/neonatal jaundice
Gilbert's syndrome, Crigler-Najjar syndrome
Ineffective erythropoiesis (megaloblastic anaemia)

Hepatic (Mixed/Conjugated):

Viral hepatitis (A, B, C, E)
Alcoholic liver disease
Drug-induced hepatitis (paracetamol, isoniazid)
Autoimmune hepatitis
Intrahepatic cholestasis (primary biliary cholangitis, primary sclerosing cholangitis)
Dubin-Johnson syndrome, Rotor syndrome

STATION 3 (10 Marks) - PLASMA GLUCOSE

Case: 46-year-old obese businessman, polyuria, polyphagia, polydipsia, weakness, numbness and tingling in hands and feet.

Q1. Probable Diagnosis (1M)

Type 2 Diabetes Mellitus with peripheral neuropathy

Classic "3 Ps" (polyuria, polydipsia, polyphagia) + obesity + peripheral neuropathy symptoms (numbness/tingling) in a middle-aged male.

Q2. Principle of Plasma Glucose Estimation (2M)

Glucose Oxidase - Peroxidase (GOD-POD) Method:

Step 1: Glucose is oxidized by the enzyme glucose oxidase (GOD) in the presence of oxygen and water to produce gluconic acid and hydrogen peroxide (H₂O₂):

Glucose + O₂ + H₂O → Gluconic acid + H₂O₂ (glucose oxidase)

Step 2: H₂O₂ reacts with a chromogen (4-aminoantipyrine + phenol) in the presence of the enzyme peroxidase (POD) to form a red-coloured quinoneimine dye:

H₂O₂ + 4-aminoantipyrine + phenol → Quinoneimine (red) + H₂O (peroxidase)

Absorbance is measured at 505 nm. Colour intensity is directly proportional to glucose concentration (Beer-Lambert Law).

Q3. Calculate Plasma Glucose Concentration (3M)

Formula:

Glucose (mg/dL) = (OD_test / OD_standard) × Concentration of standard

(Using typical practical values - exact OD provided at bench):

If OD_test = 0.45, OD_std = 0.25, Standard = 200 mg/dL:

Glucose = (0.45/0.25) × 200 = 360 mg/dL

(This elevated value is consistent with uncontrolled diabetes)

Q4. ADA Criteria for Diagnosis of Diabetes Mellitus (4M)

The American Diabetes Association (ADA) diagnostic criteria (any ONE of the following):

Criterion	Threshold
1. Fasting Plasma Glucose (FPG)	≥ 126 mg/dL (7.0 mmol/L) - fasting = no caloric intake ≥ 8 hours
2. 2-hour Plasma Glucose (75g OGTT)	≥ 200 mg/dL (11.1 mmol/L) during oral glucose tolerance test
3. HbA1c	≥ 6.5% (48 mmol/mol)
4. Random Plasma Glucose + Symptoms	≥ 200 mg/dL (11.1 mmol/L) with classic symptoms (polyuria, polydipsia, unexplained weight loss)

Pre-diabetes categories:

Impaired Fasting Glucose (IFG): FPG 100-125 mg/dL
Impaired Glucose Tolerance (IGT): 2hr OGTT 140-199 mg/dL
HbA1c 5.7 - 6.4%

Note: In the absence of hyperglycaemic crisis, criteria 1-3 should be confirmed by repeat testing on a subsequent day.

STATION 1 (10 Marks) - SERUM UREA

Case: 7-year-old girl, swollen hands (1 week), periorbital oedema (2 days), abdominal pain. History of streptococcal sore throat 3 weeks ago treated with antibiotics. Raised serum creatinine. Urinary blood (+) and proteins (+).

Q1. Probable Diagnosis (2M)

Post-streptococcal Glomerulonephritis (PSGN) / Acute Nephritic Syndrome

Evidence: Recent streptococcal throat infection → latent period of ~2-3 weeks → haematuria + proteinuria + oedema + raised creatinine = classic nephritic syndrome following Group A beta-haemolytic streptococcal (GAS) infection.

Q2. Principle of Serum Urea Estimation (2M)

Diacetyl Monoxime (DAM) Method / Urease-GLDH Method:

Enzymatic (Urease-GLDH) - most common:

Step 1: Urease hydrolyzes urea to ammonium ions (NH₄⁺) and CO₂:

Urea + H₂O → 2NH₄⁺ + CO₂ (urease)
Step 2: NH₄⁺ reacts with α-ketoglutarate and NADH in the presence of glutamate dehydrogenase (GLDH) to form glutamate. The rate of decrease in NADH absorbance at 340 nm is proportional to urea concentration.

Diacetyl Monoxime (DAM) Method: Urea condenses with diacetyl monoxime under acidic conditions and heat to form a yellow-coloured diazine compound. Absorbance is read at 540 nm; intensity is proportional to urea concentration.

Q3. Calculate Serum Urea Concentration (3M)

Formula:

Urea (mg/dL) = (OD_test / OD_standard) × Concentration of standard

(Using typical practical values):

If OD_test = 0.36, OD_std = 0.20, Std = 40 mg/dL:

Urea = (0.36/0.20) × 40 = 72 mg/dL

(Elevated above the normal range, consistent with renal impairment)

Q4. Biological Reference Range of Serum Urea (1M)

Group	Reference Range
Adults	15 - 45 mg/dL (2.5 - 7.5 mmol/L)
Children	10 - 40 mg/dL
BUN (Blood Urea Nitrogen)	7 - 20 mg/dL (Urea ÷ 2.14)

Q5. Interpretation (2M)

Serum urea is elevated (> 45 mg/dL), indicating uraemia from impaired renal function
In the clinical context: post-streptococcal immune complex deposition in glomeruli → glomerular inflammation → reduced GFR → retention of nitrogenous waste (urea, creatinine)
Haematuria and proteinuria confirm glomerular damage with breakdown of the glomerular filtration barrier
Periorbital oedema reflects hypoalbuminaemia + fluid retention from reduced GFR
This confirms Acute Nephritic Syndrome secondary to PSGN

STATION B-2 - SERUM CHOLESTEROL

Case: 40-year-old male, occasional chest pain, shortness of breath on climbing stairs. Father died of MI at 46; brother had MI at same age on cholesterol medications. Multiple xanthomas (elbow, fingers, Achilles tendons, buttocks). No diabetes, no hypertension. Normal glucose, TFTs, KFTs, LFTs.

Q1. Probable Diagnosis (1M)

Familial Hypercholesterolaemia (FH) - Autosomal dominant

Evidence: Strong family history of premature coronary artery disease, multiple tendon xanthomas (pathognomonic), no secondary causes of hypercholesterolaemia (normal glucose, thyroid, kidney, liver).

Q2. Principle of Serum Cholesterol Estimation (2M)

CHOD-PAP Method (Cholesterol Oxidase - Peroxidase Aminoantipyrine):

Step 1: Cholesterol esters are hydrolysed by cholesterol esterase (CHE) to free cholesterol and fatty acids:

Cholesterol esters + H₂O → Free cholesterol + Fatty acids (CHE)

Step 2: Free cholesterol is oxidized by cholesterol oxidase (CHOD) to produce cholest-4-en-3-one and H₂O₂:

Cholesterol + O₂ → Cholest-4-en-3-one + H₂O₂ (CHOD)

Step 3: H₂O₂ reacts with 4-aminoantipyrine (4-AAP) and phenol in the presence of peroxidase (POD) to form a red-coloured quinoneimine dye:

H₂O₂ + 4-AAP + Phenol → Quinoneimine (red) + H₂O (POD)

Absorbance is measured at 505 nm. Colour is proportional to cholesterol concentration.

Q3. Calculate Serum Cholesterol Concentration (3M)

Formula:

Cholesterol (mg/dL) = (OD_test / OD_standard) × Concentration of standard

(Using typical practical values):

If OD_test = 0.50, OD_std = 0.25, Standard = 200 mg/dL:

Cholesterol = (0.50/0.25) × 200 = 400 mg/dL

(Markedly elevated, consistent with familial hypercholesterolaemia)

Q4. Biological Reference Range of Serum Cholesterol (1M)

Classification	Total Cholesterol
Desirable	< 200 mg/dL (< 5.2 mmol/L)
Borderline High	200 - 239 mg/dL
High	≥ 240 mg/dL (≥ 6.2 mmol/L)

Q5. Interpretation (2M)

Serum cholesterol is markedly elevated (400 mg/dL) - well above the desirable level
In the context of: tendon xanthomas, family history of premature MI, no secondary causes → consistent with Familial Hypercholesterolaemia (FH)
FH is caused by mutations in the LDL receptor gene (LDLR), leading to failure of LDL clearance, accumulation of LDL-cholesterol, xanthoma formation, and accelerated atherosclerosis
Chest pain on exertion indicates significant coronary artery disease (angina)

Q6. Other Conditions with Raised Serum Cholesterol (2M)

Primary (Genetic):

Familial hypercholesterolaemia (LDL receptor defect)
Familial combined hyperlipidaemia
Polygenic hypercholesterolaemia

Secondary:

Hypothyroidism (most common secondary cause - decreased LDL receptor activity)
Diabetes mellitus (especially type 2 - insulin resistance)
Nephrotic syndrome (increased hepatic lipoprotein synthesis)
Obstructive jaundice / Cholestasis (impaired bile acid excretion)
Cushing's syndrome (excess glucocorticoids)
Anorexia nervosa
Drugs: thiazide diuretics, beta-blockers, oral contraceptives, corticosteroids

+3 more

Solve them accordingly

These are the same 6 stations from the previous set — I can see all questions clearly from the images. Here are the complete, detailed answers:

STATION 3 - PLASMA GLUCOSE (10 Marks)

Case: 46-year-old obese businessman, polyuria, polyphagia, polydipsia, weakness, numbness and tingling in hands and feet.

Q1. Probable Diagnosis (1M)

Type 2 Diabetes Mellitus with early peripheral neuropathy

The classic triad (polyuria, polydipsia, polyphagia) in an obese middle-aged male, combined with peripheral neuropathy symptoms (numbness and tingling in hands and feet), points strongly to uncontrolled Type 2 DM.

Q2. Principle of Plasma Glucose Estimation - GOD-POD Method (2M)

Glucose Oxidase - Peroxidase (GOD-POD) Enzymatic Method:

Reaction 1 - Glucose oxidase (GOD) catalyses the oxidation of glucose:

Glucose + O₂ + H₂O → Gluconic acid + H₂O₂ (GOD)

Reaction 2 - Peroxidase (POD) catalyses the oxidative coupling of a chromogen:

H₂O₂ + 4-aminoantipyrine + Phenol → Quinoneimine (red dye) + H₂O (POD)

The red-coloured quinoneimine complex is measured spectrophotometrically at 505 nm. The intensity of colour is directly proportional to the glucose concentration in the sample (Beer-Lambert Law).

Q3. Calculate Concentration of Plasma Glucose (3M)

Formula (Beer-Lambert Law):

$$\text{Glucose (mg/dL)} = \frac{\text{OD}{\text{Test}}}{\text{OD}{\text{Standard}}} \times \text{Concentration of Standard}$$

Typical OSPE bench values (exact values are provided at the practical station):

Tube	OD (Absorbance)
Blank	0.000
Standard (200 mg/dL)	0.250
Patient Test	0.450

$$\text{Glucose} = \frac{0.450}{0.250} \times 200 = \mathbf{360 \ mg/dL}$$

Result: Patient plasma glucose = 360 mg/dL (markedly elevated)

Q4. ADA Criteria for Diagnosis of Diabetes Mellitus (4M)

Any ONE of the following criteria is sufficient for diagnosis:

Criterion	Diagnostic Cut-off
1. Fasting Plasma Glucose (FPG)	≥ 126 mg/dL (7.0 mmol/L) - fasting defined as no caloric intake for ≥ 8 hours
2. 2-hour Plasma Glucose (75g OGTT)	≥ 200 mg/dL (11.1 mmol/L) during oral glucose tolerance test
3. HbA1c	≥ 6.5% (48 mmol/mol)
4. Random Plasma Glucose + Symptoms	≥ 200 mg/dL with classic hyperglycaemic symptoms (polyuria, polydipsia, unexplained weight loss)

Pre-diabetes (Intermediate Hyperglycaemia):

IFG: FPG 100-125 mg/dL
IGT: 2-hr OGTT 140-199 mg/dL
HbA1c: 5.7 - 6.4%

Note: In absence of unequivocal hyperglycaemia, criteria 1, 2, and 3 require confirmation by repeat testing on a separate day.

STATION B-2 - SERUM CHOLESTEROL (10 Marks)

Case: 40-year-old male, chest pain, dyspnoea on exertion, father died of MI at 46, brother had MI at same age (on cholesterol meds), multiple xanthomas (elbows, fingers, Achilles tendons, buttocks), normal glucose/TFT/KFT/LFTs.

Q1. Probable Diagnosis (1M)

Familial Hypercholesterolaemia (FH) - Heterozygous type

Pathognomonic features: tendon xanthomas + premature coronary artery disease in two first-degree relatives + markedly elevated cholesterol with no secondary cause.

Q2. Principle of Serum Cholesterol Estimation - CHOD-PAP Method (2M)

Cholesterol Oxidase - Peroxidase Aminoantipyrine (CHOD-PAP) Method:

Step 1: Cholesterol esterase (CHE) hydrolyses cholesterol esters to free cholesterol:

Cholesterol esters + H₂O → Free Cholesterol + Fatty Acids (CHE)

Step 2: Free cholesterol is oxidised by cholesterol oxidase (CHOD):

Cholesterol + O₂ → Cholest-4-en-3-one + H₂O₂ (CHOD)

Step 3: H₂O₂ reacts with 4-aminoantipyrine (4-AAP) and phenol in the presence of peroxidase (POD):

H₂O₂ + 4-AAP + Phenol → Quinoneimine (red dye) + H₂O (POD)

Absorbance is measured at 505 nm. Colour intensity is directly proportional to cholesterol concentration (Beer-Lambert Law).

Q3. Calculate Serum Cholesterol Concentration (3M)

Formula:

$$\text{Cholesterol (mg/dL)} = \frac{\text{OD}{\text{Test}}}{\text{OD}{\text{Standard}}} \times \text{Concentration of Standard}$$

Typical OSPE bench values:

Tube	OD (Absorbance)
Blank	0.000
Standard (200 mg/dL)	0.250
Patient Test	0.500

$$\text{Cholesterol} = \frac{0.500}{0.250} \times 200 = \mathbf{400 \ mg/dL}$$

Result: Patient serum cholesterol = 400 mg/dL (severely elevated)

Q4. Biological Reference Range of Serum Cholesterol (1M)

Classification	Total Cholesterol
Desirable	< 200 mg/dL (< 5.2 mmol/L)
Borderline High	200 - 239 mg/dL
High	≥ 240 mg/dL (≥ 6.2 mmol/L)

Q5. Interpretation (1M)

Patient's serum cholesterol (400 mg/dL) is severely elevated (> 2× the upper limit of normal)
In the context of tendon xanthomas, family history of premature MI, absence of secondary causes → confirms Familial Hypercholesterolaemia due to LDL receptor (LDLR) gene mutation
LDL receptor deficiency → impaired LDL clearance → LDL accumulation → accelerated atherosclerosis → early coronary artery disease (chest pain, dyspnoea on exertion)

Q6. Other Conditions with Raised Serum Cholesterol (2M)

Primary (Genetic):

Familial hypercholesterolaemia (LDL receptor defect)
Familial combined hyperlipidaemia
Polygenic hypercholesterolaemia
Familial dysbetalipoproteinaemia (Type III hyperlipoproteinaemia)

Secondary:

Condition	Mechanism
Hypothyroidism	Decreased LDL receptor activity (most common secondary cause)
Diabetes mellitus	Insulin resistance → increased VLDL synthesis
Nephrotic syndrome	Increased hepatic lipoprotein synthesis (compensatory)
Obstructive jaundice	Impaired bile acid secretion → reduced cholesterol excretion
Cushing's syndrome	Excess glucocorticoids stimulate lipid synthesis
Anorexia nervosa	Reduced cholesterol clearance
Drugs	Thiazides, beta-blockers, corticosteroids, ciclosporin
Pregnancy	Increased estrogen → increased VLDL

STATION 1 - SERUM UREA (10 Marks)

Case: 7-year-old girl, swollen hands (1 week), periorbital oedema (2 days), abdominal pain, streptococcal sore throat 3 weeks ago (treated with antibiotics), raised serum creatinine, urinary blood (+), urinary protein (+).

Q1. Probable Diagnosis (2M)

Post-Streptococcal Glomerulonephritis (PSGN) presenting as Acute Nephritic Syndrome

Reasoning:

Preceding Group A beta-haemolytic Streptococcal (GABHS) pharyngitis with latent period of 2-3 weeks
Classic nephritic triad: haematuria (blood in urine) + proteinuria + oedema (periorbital + peripheral)
Raised serum creatinine = impaired GFR
Typical age group (5-15 years)

Q2. Principle of Serum Urea Estimation (2M)

Urease - Glutamate Dehydrogenase (GLDH) Enzymatic Method (UV Method):

Step 1: Urease hydrolyses urea to ammonium ions:

Urea + H₂O → 2 NH₄⁺ + CO₂ (Urease)

Step 2: NH₄⁺ reacts with α-ketoglutarate and NADH in the presence of GLDH:

NH₄⁺ + α-ketoglutarate + NADH → Glutamate + NAD⁺ + H₂O (GLDH)

The rate of decrease in absorbance of NADH at 340 nm is measured. The decrease is proportional to urea concentration.

Alternative - Diacetyl Monoxime (DAM) Method: Urea condenses with diacetyl monoxime under acidic conditions and heat to form a yellow-coloured diazine compound, measured at 540 nm.

Q3. Calculate Serum Urea Concentration (3M)

Formula (for colorimetric DAM or endpoint method):

$$\text{Urea (mg/dL)} = \frac{\text{OD}{\text{Test}}}{\text{OD}{\text{Standard}}} \times \text{Concentration of Standard}$$

Typical OSPE bench values:

Tube	OD (Absorbance)
Blank	0.000
Standard (40 mg/dL)	0.200
Patient Test	0.360

$$\text{Urea} = \frac{0.360}{0.200} \times 40 = \mathbf{72 \ mg/dL}$$

Result: Patient serum urea = 72 mg/dL (elevated)

Q4. Biological Reference Range for Serum Urea (1M)

Group	Reference Range
Adults	15 - 45 mg/dL (2.5 - 7.5 mmol/L)
Children	10 - 40 mg/dL
BUN (Blood Urea Nitrogen)	7 - 20 mg/dL (Urea ÷ 2.14)

Q5. Interpretation (2M)

Serum urea (72 mg/dL) is elevated (above normal of 10-40 mg/dL for children) = azotaemia/uraemia
This is due to reduced GFR from immune complex-mediated glomerular injury
Pathophysiology: Anti-streptococcal antibodies form immune complexes → deposit in glomerular basement membrane → complement activation → inflammatory damage → reduced filtration → retention of urea, creatinine
Haematuria = RBCs leaking through damaged glomerular capillaries
Proteinuria = disrupted glomerular filtration barrier (loss of charge selectivity)
Periorbital oedema = sodium and water retention + hypoalbuminaemia
This presentation is consistent with PSGN/Acute Nephritic Syndrome, and serum urea confirms renal impairment

STATION B-2 - SERUM BILIRUBIN (10 Marks)

Case: 45-year-old male, yellowish discolouration of sclera and skin (4 days), dark urine, fatigue, mild right upper quadrant discomfort, no alcohol/medications/prior liver disease, no hepatosplenomegaly. Investigations: ALT: 100 U/L | AST: 98 U/L | ALP: 480 U/L | GGT: 250 U/L

Q1. Principle of Serum Bilirubin Estimation - Jendrassik-Grof Method (2M)

Diazo (Jendrassik and Grof) Method:

Reagent: Diazotised sulphanilic acid (diazo reagent) prepared by reacting sulphanilic acid + sodium nitrite in HCl.

Conjugated (Direct) Bilirubin: Water-soluble conjugated bilirubin reacts directly with the diazo reagent (without accelerator) to form a blue-green azo dye:

Conjugated Bilirubin + Diazo reagent → Azobilirubin (blue-green)

Total Bilirubin: An accelerator (caffeine-benzoate-acetate solution) is added to dissociate unconjugated bilirubin from albumin, allowing it to also react with the diazo reagent:

Total Bilirubin + Accelerator + Diazo reagent → Azobilirubin (blue-green)

Unconjugated (Indirect) Bilirubin:

Unconjugated Bilirubin = Total Bilirubin - Conjugated Bilirubin

Absorbance is measured at 600 nm. Colour intensity is proportional to bilirubin concentration.

Q2. Calculate Total, Conjugated, and Unconjugated Bilirubin (3M)

Formula:

$$\text{Bilirubin (mg/dL)} = \frac{\text{OD}{\text{Test}}}{\text{OD}{\text{Standard}}} \times \text{Concentration of Standard}$$

Typical OSPE bench values:

Parameter	OD (Test)	OD (Std)	Std Conc	Result
Total Bilirubin	0.400	0.250	2 mg/dL	(0.400/0.250) × 2 = 3.2 mg/dL
Conjugated (Direct)	0.320	0.250	2 mg/dL	(0.320/0.250) × 2 = 2.56 mg/dL
Unconjugated (Indirect)	-	-	-	3.2 - 2.56 = 0.64 mg/dL

Q3. Biological Reference Ranges (1M)

Parameter	Reference Range
Total Bilirubin	0.2 - 1.0 mg/dL
Conjugated (Direct) Bilirubin	0.0 - 0.3 mg/dL
Unconjugated (Indirect) Bilirubin	0.1 - 0.8 mg/dL

Q4. Interpretation (2M)

Total bilirubin elevated (3.2 mg/dL) with predominantly conjugated (direct) fraction (2.56 mg/dL = ~80% of total) = Conjugated hyperbilirubinaemia
Enzyme pattern: ALP markedly elevated (480 U/L, normal < 120 U/L) + GGT markedly elevated (250 U/L) >> ALT/AST mildly elevated (100/98 U/L) → cholestatic/obstructive pattern
No alcohol, no drugs, no prior liver disease, no hepatosplenomegaly → extrahepatic biliary obstruction most likely (e.g., choledocholithiasis - common bile duct stone)
Dark urine: conjugated bilirubin is water-soluble → excreted in urine
Pale/clay-coloured stools would be expected (bile not reaching intestine)
Conclusion: Obstructive jaundice, likely due to choledocholithiasis

Q5. Pre-hepatic and Hepatic Causes of Raised Serum Bilirubin (2M)

Pre-hepatic Causes (Unconjugated hyperbilirubinaemia - increased production):

Haemolytic anaemias: hereditary spherocytosis, G6PD deficiency, sickle cell disease, thalassaemia
Incompatible blood transfusion reactions
Neonatal/physiological jaundice
Ineffective erythropoiesis (megaloblastic anaemia)
Genetic: Gilbert's syndrome (UGT1A1 promoter variant), Crigler-Najjar syndrome (absent UGT1A1)

Hepatic Causes (Mixed or conjugated hyperbilirubinaemia):

Viral hepatitis (Hepatitis A, B, C, D, E)
Alcoholic liver disease / hepatitis
Drug-induced liver injury (paracetamol, INH, rifampicin)
Autoimmune hepatitis
Intrahepatic cholestasis: Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC)
Genetic: Dubin-Johnson syndrome, Rotor syndrome (conjugated hyperbilirubinaemia)
Sepsis-associated cholestasis

STATION B-2 - SERUM CREATININE (10 Marks)

Case: 41-year-old male, longstanding hypertension, lethargy, lower extremity oedema, nausea, diagnosed with acute renal failure.

Q1. Principle of Serum Creatinine Estimation - Jaffe's Method (1M)

Alkaline Picrate (Jaffe's) Method:

Creatinine reacts with picric acid in an alkaline medium (sodium hydroxide) to form a red-orange coloured Janovsky complex (creatinine-picric acid complex):

Creatinine + Picric acid + NaOH → Orange-red Janovsky complex

Absorbance is measured at 520 nm. Colour intensity is directly proportional to creatinine concentration (Beer-Lambert Law). The reaction is read as a kinetic (rate) reaction to minimise interference from pseudo-creatinine chromogens.

Q2. Calculate Serum Creatinine (3M)

Formula:

$$\text{Creatinine (mg/dL)} = \frac{\text{OD}{\text{Test}}}{\text{OD}{\text{Standard}}} \times \text{Concentration of Standard}$$

Typical OSPE bench values:

Tube	OD (Absorbance)
Blank	0.000
Standard (2 mg/dL)	0.200
Patient Test	0.300

$$\text{Creatinine} = \frac{0.300}{0.200} \times 2 = \mathbf{3.0 \ mg/dL}$$

Result: Patient serum creatinine = 3.0 mg/dL (markedly elevated)

Q3. Biological Reference Range of Serum Creatinine (1M)

Group	Reference Range
Adult Males	0.7 - 1.3 mg/dL (62 - 115 µmol/L)
Adult Females	0.6 - 1.1 mg/dL (53 - 97 µmol/L)
Children	0.3 - 0.7 mg/dL

Q4. Interpretation (2M)

Serum creatinine (3.0 mg/dL) is markedly elevated (> 2× the upper limit of normal) - confirms Acute Kidney Injury (AKI)
In the clinical context: longstanding hypertension → hypertensive nephrosclerosis → chronic renal injury with acute-on-chronic deterioration
GFR is severely reduced (creatinine doubles for each 50% reduction in GFR)
Lethargy + nausea = uraemic symptoms from nitrogenous waste accumulation
Lower extremity oedema = reduced GFR → sodium and water retention + fluid overload
This confirms AKI (acute renal failure) superimposed on hypertensive nephropathy

Q5. Causes of Increased Serum Creatinine Level (2M)

Pre-renal (Reduced renal perfusion):

Dehydration, haemorrhage, shock
Congestive heart failure
Renal artery stenosis
Burns, sepsis

Renal (Intrinsic kidney disease):

Acute tubular necrosis (ATN) - ischaemic or nephrotoxic
Glomerulonephritis (acute/rapidly progressive)
Hypertensive nephrosclerosis (this patient)
Diabetic nephropathy
Polycystic kidney disease
Drug nephrotoxicity (aminoglycosides, NSAIDs, contrast media, ciclosporin)
Interstitial nephritis

Post-renal (Obstruction):

Benign prostatic hyperplasia (BPH)
Renal calculi / ureteric stones
Ureteral obstruction (tumour, stricture)
Bladder outlet obstruction

Non-renal (increased creatinine production):

Rhabdomyolysis (massive muscle breakdown)
Large muscle mass / bodybuilders
High meat diet (dietary creatine converts to creatinine)

Q6. Define Creatinine Clearance (1M)

Creatinine Clearance (CrCl) is defined as the volume of plasma that is completely cleared of creatinine by the kidneys per unit time (expressed in mL/min). It serves as a clinical estimate of the Glomerular Filtration Rate (GFR).

Formula: $$\text{CrCl} = \frac{\text{Urine Creatinine (mg/dL)} \times \text{Urine Volume (mL/min)}}{\text{Serum Creatinine (mg/dL)}}$$

Cockcroft-Gault Formula (estimated CrCl): $$\text{CrCl} = \frac{(140 - \text{Age}) \times \text{Weight (kg)}}{72 \times \text{Serum Creatinine (mg/dL)}} \ (\times 0.85 \text{ for females})$$

Normal values:

Males: 85 - 125 mL/min
Females: 75 - 115 mL/min
Decreases with age and progressively with renal disease

STATION B-2 - URIC ACID / GOUT (10 Marks)

Case: 58-year-old retired major general, severe pain + swelling of right 1st MTP joint, non-vegetarian, chronic alcoholic, no trauma, mild fever, right big toe swollen/warm/red, urinary pH 4.5.

Q1. Probable Diagnosis (1M)

Acute Gouty Arthritis (Gout) - Podagra

The combination of podagra (1st MTP joint involvement), purine-rich diet (non-vegetarian), chronic alcohol use, hyperuricaemia, acidic urine, and inflammatory signs (warmth, redness, fever) is pathognomonic of acute gout.

Q2. Principle of Uric Acid Estimation (1M)

Uricase-Peroxidase (Enzymatic) Method:

Step 1: Uricase oxidises uric acid to allantoin and H₂O₂:

Uric acid + O₂ + H₂O → Allantoin + H₂O₂ + CO₂ (Uricase)

Step 2: H₂O₂ reacts with a chromogen (3,5-dichloro-2-hydroxybenzene sulphonate + 4-aminoantipyrine) in the presence of peroxidase:

H₂O₂ + Chromogen → Red quinoneimine dye + H₂O (Peroxidase)

Absorbance measured at 505 nm; intensity proportional to uric acid concentration.

Q3. Calculate Concentration of Uric Acid (3M)

Formula:

$$\text{Uric Acid (mg/dL)} = \frac{\text{OD}{\text{Test}}}{\text{OD}{\text{Standard}}} \times \text{Concentration of Standard}$$

Typical OSPE bench values:

Tube	OD (Absorbance)
Blank	0.000
Standard (10 mg/dL)	0.180
Patient Test	0.250

$$\text{Uric Acid} = \frac{0.250}{0.180} \times 10 = \mathbf{13.9 \ mg/dL}$$

Result: Patient serum uric acid = 13.9 mg/dL (severely elevated)

Q4. Biological Reference Range + Result (1M)

Group	Reference Range
Adult Males	3.5 - 7.2 mg/dL (208 - 428 µmol/L)
Adult Females	2.6 - 6.0 mg/dL (155 - 357 µmol/L)

Result: 13.9 mg/dL is above the normal range for males → Hyperuricaemia

Q5. Interpretation (2M)

Serum uric acid is markedly elevated (13.9 mg/dL vs. normal < 7.2 mg/dL in males) = severe hyperuricaemia
Contributing factors in this patient:
- High purine diet (non-vegetarian - red meat, organ meats rich in purines)
- Chronic alcohol (increases uric acid production by accelerating ATP degradation; lactic acid from alcohol competes with uric acid for renal excretion)
- Acidic urine (pH 4.5): uric acid is poorly soluble in acid urine → promotes urate crystal deposition in joints and renal tubules (risk of uric acid stones)
Monosodium urate (MSU) crystals deposit in the 1st MTP joint → phagocytosis by neutrophils → inflammatory cascade → acute gouty arthritis
Conclusion: Hyperuricaemia causing acute gout (podagra)

Q6. Other Conditions with Raised Serum Uric Acid (2M)

Increased Uric Acid Production:

Condition	Mechanism
Lesch-Nyhan syndrome	HGPRT enzyme deficiency → excess purine synthesis
Leukaemia / Lymphoma	Rapid cell turnover → increased nucleic acid breakdown
Polycythaemia vera	Increased RBC turnover
Tumour Lysis Syndrome	Massive cell death after chemotherapy
Haemolytic anaemia	Increased RBC breakdown
Psoriasis	Increased skin cell turnover

Decreased Renal Excretion:

Condition	Mechanism
Chronic kidney disease	Reduced GFR
Hypertension	Reduced renal blood flow
Hypothyroidism	Reduced GFR + reduced tubular secretion
Drugs	Thiazide diuretics, low-dose aspirin, ciclosporin, pyrazinamide, ethambutol
Lead nephropathy (Saturnine gout)	Tubular damage
Starvation / fasting	Lactic acidosis competes with uric acid excretion

This is a shared conversation. Sign in to Orris to start your own chat.